Progression despite replacement of a myopathic form of coenzyme Q10 defect.

Auré, K; Benoist, J F; Ogier de Baulny, H; Romero, N B; Rigal, O; Lombès, A

Auré, K; Benoist, J F; Ogier de Baulny, H; Romero, N B; Rigal, O; Lombès, A.

Affiliation

Auré K; INSERM U582, Institut de Myologie, Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.

Neurology ; 63(4): 727-9, 2004 Aug 24.

Article in En | MEDLINE | ID: mdl-15326254

Subject(s)

Cerebellar Ataxia/genetics; Exercise Tolerance/genetics; Lactates/blood; Mitochondrial Myopathies/genetics; Ubiquinone/deficiency; Benzoquinones/adverse effects; Benzoquinones/therapeutic use; Carnitine/therapeutic use; Cerebellum/pathology; Child, Preschool; Disease Progression; Drug Therapy, Combination; Exercise Tolerance/drug effects; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Mitochondria, Muscle/chemistry; Mitochondrial Myopathies/complications; Mitochondrial Myopathies/drug therapy; Mitochondrial Myopathies/metabolism; Muscle, Skeletal/pathology; Treatment Failure; Ubiquinone/pharmacokinetics; Ubiquinone/therapeutic use; Vomiting/etiology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Cerebellar Ataxia / Ubiquinone / Mitochondrial Myopathies / Exercise Tolerance / Lactates Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links